UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 747

Sortiert nach

Efficacy and Safety of Lapatinib As First-Line Therapy for ErbB2-Amplified Locally Advanced or Metastatic Breast Cancer

Journal of clinical oncology, 2008-06, Vol.26 (18), p.2999-3005

2008

Link zum Volltext

Verfügbarkeit prüfen

CBR1 and CBR3 pharmacogenetics and their influence on doxorubicin disposition in Asian breast cancer patients

Cancer science, 2008-10, Vol.99 (10), p.2045-2054

2008

Link zum Volltext

Verfügbarkeit prüfen

Influence of ABCB1 and ABCG2 polymorphisms on doxorubicin disposition in Asian breast cancer patients

Cancer science, 2008-04, Vol.99 (4), p.816-823

2008

Link zum Volltext

Verfügbarkeit prüfen

Impact of UDP-gluconoryltransferase 2B17 genotype on vorinostat metabolism and clinical outcomes in Asian women with breast cancer

Pharmacogenetics and genomics, 2011-11, Vol.21 (11), p.760-768

2011

Link zum Volltext

Verfügbarkeit prüfen

Improving indel detection specificity of the Ion Torrent PGM benchtop sequencer

PloS one, 2012-09, Vol.7 (9), p.e45798

2012

Link zum Volltext

Verfügbarkeit prüfen

Neratinib + capecitabine sustains health-related quality of life in patients with HER2-positive metastatic breast cancer and ≥ 2 prior HER2-directed regimens

Breast cancer research and treatment, 2021-07, Vol.188 (2), p.449-458

2021

Link zum Volltext

Verfügbarkeit prüfen

Whole-exome sequencing of BRCA-negative breast cancer patients and case-control analyses identify variants associated with breast cancer susceptibility

Human genomics, 2022-11, Vol.16 (1), p.61-15, Article 61

2022

Link zum Volltext

Verfügbarkeit prüfen

Machine learning unveils an immune-related DNA methylation profile in germline DNA from breast cancer patients

Clinical epigenetics, 2024-05, Vol.16 (1), p.66-66, Article 66

2024

Link zum Volltext

Verfügbarkeit prüfen

Correction: Whole-exome sequencing of BRCA-negative breast cancer patients and case-control analyses identify variants associated with breast cancer susceptibility

Human genomics, 2022-12, Vol.16 (1), p.68-68, Article 68

2022

Link zum Volltext

Verfügbarkeit prüfen

Correction: Landscape of germline pathogenic variants in patients with dual primary breast and lung cancer

Human genomics, 2023-08, Vol.17 (1), p.74-74, Article 74

2023

Link zum Volltext

Verfügbarkeit prüfen

Landscape of germline pathogenic variants in patients with dual primary breast and lung cancer

Human genomics, 2023-07, Vol.17 (1), p.66-66, Article 66

2023

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of three polygenic risk score models for the prediction of breast cancer risk in Singapore Chinese

Oncotarget, 2018-02, Vol.9 (16), p.12796-12804

2018

Link zum Volltext

Verfügbarkeit prüfen

Predictive Factors for BRCA1 and BRCA2 Genetic Testing in an Asian Clinic-Based Population

PloS one, 2015-07, Vol.10 (7), p.e0134408-e0134408

2015

Link zum Volltext

Verfügbarkeit prüfen

Randomized Double-Blind Trial of Combined Modality Treatment With or Without Amifostine in Unresectable Stage III Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2003-05, Vol.21 (9), p.1767-1774

2003

Link zum Volltext

Verfügbarkeit prüfen

Novel SLC22A16 polymorphisms and influence on doxorubicin pharmacokinetics in Asian breast cancer patients

Pharmacogenomics, 2007-06, Vol.8 (6), p.567-575

2007

Link zum Volltext

Verfügbarkeit prüfen

Validation of the Gail model for predicting individual breast cancer risk in a prospective nationwide study of 28,104 Singapore women

Breast cancer research : BCR, 2012-01, Vol.14 (1), p.R19-R19, Article R19

2012

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of Nanofluidics Technology for High-Throughput SNP Genotyping in a Clinical Setting

The Journal of molecular diagnostics : JMD, 2011-05, Vol.13 (3), p.305-312

2011

Link zum Volltext

Verfügbarkeit prüfen

PXR Pharmacogenetics: Association of Haplotypes with Hepatic CYP3A4 and ABCB1 Messenger RNA Expression and Doxorubicin Clearance in Asian Breast Cancer Patients

Clinical cancer research, 2008-11, Vol.14 (21), p.7116-7126

2008

Link zum Volltext

Verfügbarkeit prüfen

BRCA1 and BRCA2 Mutations in an Asian Clinic-based Population Detected Using a Comprehensive Strategy

Cancer epidemiology, biomarkers & prevention, 2007-11, Vol.16 (11), p.2276-2284

2007

Link zum Volltext

Verfügbarkeit prüfen

Engineering Photorhabdus luminescens toxin complex (PTC) into a recombinant injection nanomachine

Life science alliance, 2019-10, Vol.2 (5), p.e201900485

2019

Link zum Volltext

Verfügbarkeit prüfen

Development of a Next-Generation Sequencing Method for BRCA Mutation Screening

The Journal of molecular diagnostics : JMD, 2012-11, Vol.14 (6), p.602-612

2012

Link zum Volltext

Verfügbarkeit prüfen

Breast carcinoma in women 35 years and younger: a pathological study

Pathology, 2006-06, Vol.38 (3), p.219-222

2006

Link zum Volltext

Verfügbarkeit prüfen

Conservation and reintroduction of native orchids of Singapore – the next phase

European Journal of Environmental Sciences (On-line), 2012-02, Vol.1 (2), p.38-47

2012

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 747

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(635)
Mit Volltextzugriff
(657)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(703)
Japanisch
(91)
Deutsch
(41)
Spanisch
(1)
Norwegisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(482)
Life Sciences & Biomedicine
(366)
Humans
(304)
Female
(174)
Male
(169)
Adult
(116)
Middle Aged
(116)
Aged
(85)
Biological And Medical Sciences
(77)
Animals
(71)
Medical Sciences
(60)
Technology
(59)
Science & Technology - Other Topics
(48)
Neurosciences & Neurology
(47)
Physical Sciences
(47)
Oncology
(44)
Risk Factors
(44)
Treatment Outcome
(44)
Young Adult
(44)
Multidisciplinary Sciences
(41)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(16)
... seit 30 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Efficacy and Safety of Lapatinib As First-Line Therapy for ErbB2-Amplified Locally Advanced or Metastatic Breast Cancer

Analysis of the pan-Asian subgroup of patients in the NALA Trial: a randomized phase III NALA Trial comparing neratinib+capecitabine (N+C) vs lapatinib+capecitabine (L+C) in patients with HER2+metastatic breast cancer (mBC) previously treated with two or more HER2-directed regimens

CBR1 and CBR3 pharmacogenetics and their influence on doxorubicin disposition in Asian breast cancer patients

Influence of ABCB1 and ABCG2 polymorphisms on doxorubicin disposition in Asian breast cancer patients

Impact of UDP-gluconoryltransferase 2B17 genotype on vorinostat metabolism and clinical outcomes in Asian women with breast cancer

Improving indel detection specificity of the Ion Torrent PGM benchtop sequencer

Neratinib + capecitabine sustains health-related quality of life in patients with HER2-positive metastatic breast cancer and ≥ 2 prior HER2-directed regimens

Whole-exome sequencing of BRCA-negative breast cancer patients and case-control analyses identify variants associated with breast cancer susceptibility

Machine learning unveils an immune-related DNA methylation profile in germline DNA from breast cancer patients

Correction: Whole-exome sequencing of BRCA-negative breast cancer patients and case-control analyses identify variants associated with breast cancer susceptibility

Correction: Landscape of germline pathogenic variants in patients with dual primary breast and lung cancer

Landscape of germline pathogenic variants in patients with dual primary breast and lung cancer

Evaluation of three polygenic risk score models for the prediction of breast cancer risk in Singapore Chinese

Predictive Factors for BRCA1 and BRCA2 Genetic Testing in an Asian Clinic-Based Population

Randomized Double-Blind Trial of Combined Modality Treatment With or Without Amifostine in Unresectable Stage III Non–Small-Cell Lung Cancer

Novel SLC22A16 polymorphisms and influence on doxorubicin pharmacokinetics in Asian breast cancer patients

Validation of the Gail model for predicting individual breast cancer risk in a prospective nationwide study of 28,104 Singapore women

Evaluation of Nanofluidics Technology for High-Throughput SNP Genotyping in a Clinical Setting

PXR Pharmacogenetics: Association of Haplotypes with Hepatic CYP3A4 and ABCB1 Messenger RNA Expression and Doxorubicin Clearance in Asian Breast Cancer Patients

BRCA1 and BRCA2 Mutations in an Asian Clinic-based Population Detected Using a Comprehensive Strategy

Engineering Photorhabdus luminescens toxin complex (PTC) into a recombinant injection nanomachine

Development of a Next-Generation Sequencing Method for BRCA Mutation Screening

Breast carcinoma in women 35 years and younger: a pathological study

Cross‐Ancestry Genome‐Wide Association Study Defines the Extended CYP2D6 Locus as the Principal Genetic Determinant of Endoxifen Plasma Concentrations

Conservation and reintroduction of native orchids of Singapore – the next phase

Suchergebnisse filtern